The Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?

Cancer journal (Sudbury, Mass.) Vol. 28 (2) : 93-95 • Mar 2022

No abstract available for this paper

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.

PICO extraction requires an abstract.

PMID: 35333491

DOI: 10.1097/PPO.0000000000000582 [doi]

Publication Year: 2022

Language: e, n, g

No associated datasets or code repositories found for this paper.

Related paper suggestions will be available in future updates.